Suppr超能文献

早期目标导向治疗对感染性休克患者预后的改善作用

[Improvement effect of early goal-directed therapy on the prognosis in patients with septic shock].

作者信息

Li Chang, Yun Dong

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Nov;27(11):899-905.

Abstract

OBJECTIVE

To evaluate the effect of the early goal-directed therapy (EGDT) on mortality in patients with septic shock, and to analyze the risk factors of mortality.

METHODS

A retrospective controlled study was conducted. Complete clinical data of patients with septic shock admitted to emergency intensive care unit (EICU) of Sichuan Provincial People's Hospital from May 1994 to December 2014 were recorded and analyzed. According to the International Guidelines for Management of Severe Sepsis and Septic Shock ( SSC ) with the time of promulgation as dividing point, the patients were divided into two groups as before and after the publication of the guideline, i.e. early group (from May 1994 to April 2004) and late group (from May 2004 to December 2014). The patients of the late group were subdivided into 6-hour and 24-hour reaching standard groups and non-reaching standard group according to the time of reaching standard of EGDT. All patients were divided into death group and survival group according to the 28-day survival. The patients in early group were not treated according to EGDT guidance, so only age, the case history of chronic disease, the main site of infection, organ dysfunction, vital signs, urine output, the amount of fluid for resuscitation, blood routine, blood gas analysis, time for starting antibiotics treatment, the use of vasoactive drugs and hormone, etc. were recorded. The central venous pressure (CVP), central venous oxygen saturation (ScvO₂), blood lactate (Lac), and the monitor of other parameters of patients in late group were consummated late. The relationship of EGDT compliance standard time and tissue perfusion index recovery time between the two groups of patients was observed. The risk factor for mortality was analyzed by multiple factors logistic regression.

RESULTS

(1) 134 patients were included, and the overall 28-day mortality was 49.25%. (2) The 6-hour EGDT compliance rate of early group was 0 (0/58), and it was 28.95% (22/76) in late group (χ² = 20.087, P = 0.000). Compared with the early group, the 6-hour urine volume in the late group was significantly increased (mL · h⁻¹ · kg⁻¹: 1.72 ± 1.04 vs. 0.89 ± 0.24, t = 11.950, P = 0.001), 6-hour mean arterial pressure (MAP, mmHg, 1 mmHg = 0.133 kPa) was elevated (64.24 ± 3.90 vs. 56.21 ± 5.95, t = 6.444, P = 0.012), the use of antibiotics within 1 hour was increased (76.32% vs. 48.28%, χ² = 11.250, P = 0.001), the use of vasocative drugs (21.05% vs. 89.66%, χ² = 61.942, P = 0.000) and hormone (8.57% vs. 34.48%, χ² = 14.871, P = 0.000) were lowered, and the 28-day mortality rate was lowered significantly [34.21% (26/76) vs. 68.96% (40/58), χ² = 15.897, P = 0.000]. The difference was not statistically significant in the total recovery of liquid volume between late group and early group (mL: 1,856.31 ± 805.81 vs. 1,903.1 ± 897.11, t = 0.101, P = 0.752). (3) In all patients, it was shown by single factor analysis that the age, infection sites , altered mental status at admission, white blood cell (WBC) before treatment, 6-hour urine output after treatment, the number of organ with failure, the use of antibiotics within 1 hour, and incidence of acute renal injury (AKI) or acute lung injury/acute respiratory distress syndrome (ALI/ARDS) within 24 hours were risk factors of 28-day death (P < 0.05 or P < 0.01). In the late group, it was shown by single factor analysis that the age, the case history of chronic disease, infection sites, WBC, pH value, Lac, and ScvO₂ before treatment, 6-hour urine output after treatment, the number of organ with failure, the use of antibiotics within 1 hour, and incidence of AKI or ALI/ARDS within 24 hours were risk factors of 28-day death (P < 0.05 or P < 0.01). It was shown by the logistic regression analysis that aging [odds ratio (OR) = 4.81, P = 0.02], failure of 2 organs (OR = 28.63, P = 0.00) or ≥ 3 organs (OR = 62.69, P = 0.00) were the independent risk factors for mortality in patients with septic shock. (4) The 76 patients of late group were subdivided into three groups, namely 6-hour reaching standard of EGDT group (n = 22), 24-hour reaching standard of EGDT group (n = 28), and non-reaching standard of EGDT group (n = 28). Compared with those before treatment, the Lac after therapy was decreased obviously both in 6-hour EGDT group and 24-hour EGDT group, and the CVP, MAP, and ScvO2 were increased significantly. The Lac in 6-hour EGDT group was lowered more significantly as compared with that in 24-hour EGDT group (mmol/L: 1.64 ± 0.40 vs. 3.01 ± 1.13, P < 0.01), while MAP and ScvO2 were increased significantly [MAP (mmHg): 81.82 ± 18.01 vs. 69.01 ± 9.63; ScvO₂: 0.718 ± 0.034 vs. 0.658 ± 0.036, P < 0.05 and P < 0.01]. The urine output in both reaching standard of EGDT groups was more than 0.5 mL · h⁻¹ · kg⁻¹ without statistically different significance. The 28-day mortality rate of 24-hour EGDT group was 14.29%, and it was 0 in 6-hour EGDT group.

CONCLUSIONS

Mortality was as high as 68.96% during 10 years when the period before the use of 2004 SSC, and the mortality rate was lowered to 34.21% during 10 years during which the early fluid resuscitation treatment was based on EGDT. Aging and failure of more than 2 organs were independent risk factors for mortality in patients with septic shock. Compared with reaching the standard of EGDT within 24 hours, reaching the standard of EGDT within 6 hours can rapidly reverse hypoxic-ischemic tissue, thereby improving the prognosis of the patient with lowering of mortality rate.

摘要

目的

评估早期目标导向治疗(EGDT)对感染性休克患者死亡率的影响,并分析死亡的危险因素。

方法

进行一项回顾性对照研究。记录并分析1994年5月至2014年12月在四川省人民医院急诊重症监护病房(EICU)收治的感染性休克患者的完整临床资料。根据《严重脓毒症和感染性休克治疗国际指南》(SSC)的颁布时间作为分界点,将患者分为指南颁布前、后两组,即早期组(1994年5月至2004年4月)和晚期组(2004年5月至2014年12月)。晚期组患者根据EGDT达标时间分为6小时达标组、24小时达标组和未达标组。所有患者根据28天生存情况分为死亡组和生存组。早期组患者未按照EGDT指导进行治疗,仅记录年龄、慢性病病史、主要感染部位、器官功能障碍、生命体征、尿量、复苏液体量、血常规、血气分析、开始抗生素治疗时间、血管活性药物和激素的使用等情况。晚期组患者的中心静脉压(CVP)、中心静脉血氧饱和度(ScvO₂)、血乳酸(Lac)及其他参数监测完善较晚。观察两组患者EGDT达标标准时间与组织灌注指数恢复时间的关系。采用多因素logistic回归分析死亡的危险因素。

结果

(1)共纳入134例患者,总体28天死亡率为49.25%。(2)早期组6小时EGDT达标率为0(0/58),晚期组为28.95%(22/76)(χ² = 20.087,P = 0.000)。与早期组相比,晚期组6小时尿量显著增加(mL·h⁻¹·kg⁻¹:1.72±1.04 vs. 0.89±0.24,t = 11.950,P = 0.001),6小时平均动脉压(MAP,mmHg,1 mmHg = 0.133 kPa)升高(64.24±3.90 vs. 56.21±5.95,t = 6.444,P = 0.012),1小时内使用抗生素的比例增加(76.32% vs. 48.28%,χ² = 11.250,P = 0.001),血管活性药物(21.05% vs. 89.66%,χ² = 61.942,P = 0.000)和激素(8.57% vs. 34.48%,χ² = 14.871,P = 0.000)的使用比例降低,28天死亡率显著降低[34.21%(26/76)vs. 68.96%(40/58),χ² = 15.897,P = 0.000]。晚期组与早期组液体总量恢复差异无统计学意义(mL:1,856.31±805.81 vs. 1,903.1±897.11,t = 0.101,P = 0.752)。(3)单因素分析显示,所有患者中年龄、感染部位、入院时意识改变、治疗前白细胞(WBC)、治疗后6小时尿量、器官衰竭数量、1小时内使用抗生素情况及24小时内急性肾损伤(AKI)或急性肺损伤/急性呼吸窘迫综合征(ALI/ARDS)的发生率是28天死亡的危险因素(P < 0.05或P < 0.01)。晚期组单因素分析显示,年龄、慢性病病史、感染部位、WBC、pH值、Lac、治疗前ScvO₂、治疗后6小时尿量、器官衰竭数量、1小时内使用抗生素情况及24小时内AKI或ALI/ARDS的发生率是28天死亡的危险因素(P < 0.05或P < 0.01)。logistic回归分析显示,年龄增长[比值比(OR) = 4.81,P = 0.02]、2个器官衰竭(OR = 28.63,P = 0.00)或≥3个器官衰竭(OR = 62.69,P = 0.00)是感染性休克患者死亡的独立危险因素。(4)晚期组76例患者分为三组,即EGDT 6小时达标组(n = 22)、EGDT 24小时达标组(n = 28)和EGDT未达标组(n = 28)。与治疗前相比,EGDT 6小时达标组和EGDT 24小时达标组治疗后Lac均明显降低,CVP、MAP和ScvO2均显著升高。EGDT 6小时达标组Lac降低幅度明显大于EGDT 24小时达标组(mmol/L:1.64±0.40 vs. 3.01±1.13,P < 0.01),而MAP和ScvO2升高更显著[MAP(mmHg):81.82±18.01 vs. 69.01±9.63;ScvO₂:0.718±0.034 vs. 0.658±0.036,P < 0.05和P < 0.01]。EGDT达标组尿量均超过0.5 mL·h⁻¹·kg⁻¹,差异无统计学意义。EGDT 24小时达标组28天死亡率为14.29%,EGDT 6小时达标组为0。

结论

2004年SSC使用前10年死亡率高达68.96%,基于EGDT进行早期液体复苏治疗的10年期间死亡率降至34.21%。年龄增长和2个以上器官衰竭是感染性休克患者死亡的独立危险因素。与24小时内达到EGDT标准相比,6小时内达到EGDT标准可迅速逆转缺氧缺血组织,从而降低死亡率,改善患者预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验